A detailed history of Intrepid Financial Planning Group LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Intrepid Financial Planning Group LLC holds 1,875 shares of MRNA stock, worth $123,281. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,875
Holding current value
$123,281
% of portfolio
0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$101.21 - $166.61 $189,768 - $312,393
1,875 New
1,875 $222,000
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $207,905 - $313,447
1,775 New
1,775 $254,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Intrepid Financial Planning Group LLC Portfolio

Follow Intrepid Financial Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrepid Financial Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrepid Financial Planning Group LLC with notifications on news.